Showing 1 - 10 of 818
requiring instruments. In this article, we formulate the regressor endogeneity problem using a novel conditional copula … assumption of Gaussian copula regressor-error dependence structure and eliminates unnecessary modeling of regressors. Under the … model, we develop an instrument-free two-stage nonparametric copula endogeneity control function approach (2sCOPE-np), which …
Persistent link: https://www.econbiz.de/10015361483
This paper presents a new multivariate copula-based modeling approach for analyzing cost-offsets between drug and …
Persistent link: https://www.econbiz.de/10012463458
-free methods using copulas to address the endogeneity problem. The existing copula correction method focuses only on the endogenous … distributed endogenous regressors cause model non-identification or finite-sample poor performance. Our proposed two-stage copula …
Persistent link: https://www.econbiz.de/10012814483
Regression discontinuity designs (RDDs) are a popular method to estimate treatment effects. However, RDDs may fail to yield consistent estimates if the forcing variable can be manipulated by the agent. In this paper, we examine one interesting set of economic models with such a feature....
Persistent link: https://www.econbiz.de/10012461014
Under the assumption of no unmeasured confounders, a large literature exists on methods that can be used to estimating average treatment effects (ATE) from observational data and that spans regression models, propensity score adjustments using stratification, weighting or regression and even the...
Persistent link: https://www.econbiz.de/10012464559
This paper addresses estimation of an outcome characterized by mass at zero, significant skewness, and heteroscedasticity. Unlike other approaches suggested recently that require retransformations or arbitrary assumptions about error distributions, our estimation strategy uses sequences of...
Persistent link: https://www.econbiz.de/10012470794
As part of the process of enacting the Medicare Catastrophic Coverage Act (MCCA) in 1988, both the Congressional Budget Office (CBO) and the Department of Health and Human Services (HHS) estimated the cost of the pharmaceutical part of the proposal which varied substantially. For some benefit...
Persistent link: https://www.econbiz.de/10012472526
Health expenditure data almost always include extreme values. Such heavy tails can be a threat to the commonly adopted least squares methods. To accommodate extreme values, we propose the use of an estimation method that recovers the often ignored right tail of health expenditure distributions....
Persistent link: https://www.econbiz.de/10014322831
In structural dynamic discrete choice models, unobserved and mis-measured state variables may lead to biased parameter estimates and misleading inference. In this paper, we show that instrumental variables can address such measurement problems when they relate to state variables that evolve...
Persistent link: https://www.econbiz.de/10012480786
Let Y be an outcome of interest, X a vector of treatment measures, and W a vector of pre-treatment control variables. Here X may include (combinations of) continuous, discrete, and/or non-mutually exclusive "treatments". Consider the linear regression of Y onto X in a subpopulation homogenous in...
Persistent link: https://www.econbiz.de/10012480885